Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A woman got severe scalp burns from a salon's improper hair bleaching treatment.

In this case report, the researchers observed that a woman with longstanding Alopecia Universalis, who had not responded to various treatments, experienced hair regrowth and improved quality of life after two years of individualized homeopathic treatment centered around Natrum Muriaticum.

This narrative review found a strong association between alopecia areata and autoimmune thyroid diseases, suggesting routine thyroid function and autoantibody screening could be beneficial for certain patients with extensive, recurrent, or early-onset alopecia areata.

This study reviewed a traditional siddha hair treatment using quail bone ash and sesame oil, observing reduced hair fall and stimulation of new growth, though it suggests further scientific and clinical validation is needed for these findings.

In this case study, a young adult male with chronic hair loss linked to emotional stress was successfully treated with individualized homeopathic constitutional remedies over 12 months, highlighting the potential holistic benefits of homeopathy for managing hair disorders as reported by Dr. Batra's.

In this study, young Ukrainian men with alopecia areata were found to generally have higher body circumference measurements, particularly in the upper limbs, lower limbs, and trunk, compared to healthy controls, suggesting potential markers for the disease and aiding personalized diagnosis and treatment approaches.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

This review identifies a significant link between telogen effluvium and increased psychological distress, including anxiety, depression, and social phobia, stressing the need for both medical and psychological care to improve affected individuals' quality of life.

This article explores the different types of alopecia, their causes, and treatment options, emphasizing the impact of hair loss on appearance and mental health. However, it does not report specific study results.

This study reports that ritlecitinib, when used for up to 24 months in patients aged 12 and older with alopecia areata, has an acceptable safety profile, with a similar proportion of adverse events in both ritlecitinib and placebo groups in the placebo-controlled cohort.

In this study conducted at a tertiary care hospital in Karachi, oral Apremilast significantly reduced the severity of alopecia areata, shown by a notable decrease in SALT Scores over 12 weeks, suggesting it may be an effective alternative treatment option for this condition.

This article reviews the phases of hair growth and differences between androgenetic alopecia and telogen effluvium but provides no new clinical findings on Electric Follicle Stimulation.

This study found that applying pet ether extract of Brassica oleracea to rats' skin promoted earlier and longer anagen phases in hair growth, outperforming 1% minoxidil.

In this study, pig oil was found to significantly promote hair growth in Wister rats, performing better than the standard Minoxidil treatment from the 15th day onward.

This review found that hair transplantation, particularly techniques like follicular unit extraction, has become a preferred and successful surgical strategy for treating androgenetic alopecia, despite undergoing continuous development without standardized recommendations.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

This review discusses immune pathways involved in alopecia areata and explores emerging, more targeted therapeutic strategies, noting their potential for better safety and effectiveness compared to traditional immune suppressants.

In this observational study, researchers found that socioeconomic factors and stress significantly influence alopecia areata in patients in the Indian subcontinent.

In this study, a 33-year-old HIV-infected man experienced alopecia areata after beginning zidovudine therapy, which reversed upon discontinuation.

This case report describes a 15-year-old girl with Alopecia Universalis and psychiatric conditions experiencing hair regrowth after self-medicating with cannabis, suggesting it may have therapeutic potential.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

This review discusses alopecia areata as a model for studying tissue-directed autoimmune diseases and reports no new clinical findings.

This study found that videodermoscopy reveals distinct dermoscopic features in patients with alopecia areata incognita, aiding in biopsy decisions by identifying the appropriate sampling area and potentially avoiding unnecessary procedures.

This article discusses the evaluation and management of a 45-year-old woman with diffuse scalp-hair loss and reports no new clinical findings.

This study found that while some patients with severe alopecia areata responded to high-dose prednisolone, the response was inconsistent and the therapy's risks prevent recommending it for general use.

This review suggests that androgenetic alopecia may be exacerbated by exposure to ultraviolet radiation and proposes considering it as a photoaggravated condition requiring photoprotection.

This study reports that C3H/HeJ mice and DEBR rats serve as effective models for screening potential treatments for human alopecia areata, despite certain challenges in predictability and cost.

This review highlights the challenges in treating alopecia areata, noting that current therapies often lead to relapse and have uncertain long-term effectiveness; it also points to potential future treatments such as JAK-STAT inhibitors and PRP.

In this study, four women with chronic telogen effluvium experienced fluctuating hair shedding without visible reduction in hair density or follicular miniaturization over at least 7 years.

This article discusses the etiology, clinical features, diagnosis, histopathology, and treatment of alopecia areata but reports no new clinical findings; it emphasizes the palliative nature of current treatments.